Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Infinium Pharmachem Limited (NSE: INFINIUM), ISIN INE0MRE01011 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
INFINIUM last traded at ₹265.00 (-0.71%), with a 52-week range of ₹189.40 to ₹285.50 (as of 23 Sep 2026).
Shareholding as of Mar 2026: promoters 64.91%, FIIs 0.00%, DIIs 0.21%, mutual funds 0.00%.
EquiSense Score (ECS): 83/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.